Douglas L Hayden
Overview
Explore the profile of Douglas L Hayden including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
1751
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Forman J, Scott J, Ng K, Drake B, Suarez E, Hayden D, et al.
Hypertension
. 2013 Mar;
61(4):779-85.
PMID: 23487599
Blacks have significantly higher rates of hypertension than whites, and lower circulating levels of 25-hydroxyvitamin D. There are few data about the effect of vitamin D3 (cholecalciferol) supplementation on blood...
12.
Burnett-Bowie S, Leder B, Henao M, Baldwin C, Hayden D, Finkelstein J
Clin J Am Soc Nephrol
. 2012 Feb;
7(4):624-31.
PMID: 22300739
Background And Objectives: Fibroblast growth factor 23 is a phosphate- and vitamin D-regulating hormone. The objective of this study was to determine the effect of ergocalciferol administration on fibroblast growth...
13.
Xiao W, Mindrinos M, Seok J, Cuschieri J, Cuenca A, Gao H, et al.
J Exp Med
. 2011 Nov;
208(13):2581-90.
PMID: 22110166
Human survival from injury requires an appropriate inflammatory and immune response. We describe the circulating leukocyte transcriptome after severe trauma and burn injury, as well as in healthy subjects receiving...
14.
Cobb J, Hayden D, Schoenfeld D
Crit Care Med
. 2011 Oct;
39(11):2579-81.
PMID: 22005238
No abstract available.
15.
Healy B, Arora A, Hayden D, Ceccarelli A, Tauhid S, Neema M, et al.
J Neuroimaging
. 2011 Aug;
22(3):e12-9.
PMID: 21854479
Background And Purpose: To determine the proper method for the normalization of spinal cord volume. Materials And Methods: A group of 34 multiple sclerosis (MS) patients (28 relapsing and 6...
16.
Warren H, Elson C, Hayden D, Schoenfeld D, Cobb J, Maier R, et al.
Mol Med
. 2009 Jul;
15(7-8):220-7.
PMID: 19593405
Traumatic injuries frequently lead to infection, organ failure, and death. Health care providers rely on several injury scoring systems to quantify the extent of injury and to help predict clinical...
17.
Healy B, Hayden D, Sampat M, Bakshi R, Guttmann C
J Neurol Sci
. 2009 Jan;
278(1-2):54-9.
PMID: 19121526
Gadolinium-enhancing lesions in the brain are commonly used as a primary outcome measure of disease activity in phase I/II clinical trials in multiple sclerosis (MS). The advent of effective therapy...
18.
Comparison of the SpO2/FIO2 ratio and the PaO2/FIO2 ratio in patients with acute lung injury or ARDS
Rice T, Wheeler A, Bernard G, Hayden D, Schoenfeld D, Ware L
Chest
. 2007 Jun;
132(2):410-7.
PMID: 17573487
Background: The diagnostic criteria for acute lung injury (ALI) and ARDS utilize the Pao(2)/fraction of inspired oxygen (Fio(2)) [P/F] ratio measured by arterial blood gas analysis to assess the degree...
19.
Hager D, Krishnan J, Hayden D, Brower R
Am J Respir Crit Care Med
. 2005 Aug;
172(10):1241-5.
PMID: 16081547
Use of a volume- and pressure-limited mechanical ventilation strategy improves clinical outcomes of patients with acute lung injury and acute respiratory distress syndrome (ALI/ARDS). However, the extent to which tidal...
20.
Baker H, Bankey P, Billiar T, Brownstein B, Calvano S, Camp D, et al.
Proc Natl Acad Sci U S A
. 2005 Mar;
102(13):4801-6.
PMID: 15781863
The application of genome-wide expression analysis to a large-scale, multicentered program in critically ill patients poses a number of theoretical and technical challenges. We describe here an analytical and organizational...